This is a synthetic peptide designed for use in combination with anti-MYH9 antibody (Catalog #: ARP48072_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
Protein Interaction Partner: ASCC2,CD163,CXCR4,GRIN1,MEN1,MYBPC3,MYH10,MYL9,MYOM1,MYOM2,OVGP1,PTPN6,S100A4,TTN,TUFM,ASCC2,EPB41,MARK4,MYL9,PRKCE,USP1,USP45